Gustave Roussy immune score as an independent prognostic factor for treatment response and survival in advanced renal cell carcinoma treated with nivolumab in second-line and beyond.

Front Oncol · 2025 · PMC12571565 · PMID 41179670

Europe PMC DOI

hedged sentences

0.0900

closest p · 1.8× alpha

0.0900

boldest claim

The sentences

borderline significancep = 0.09so close (0.05 < p ≤ 0.1)

The poor-risk group demonstrated borderline significance, with a trend toward worse OS compared to the low/intermediate group (HR: 1.76, 95% CI: 0.93–3.42, p = 0.09).

also in 7,017 other papers

borderline significantno p-value reported

In the univariate analysis for OS, three clinical parameters were identified as significant or borderline significant prognostic factors.

also in 11,409 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.